Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.46 |
| ▸ | MET | P08581 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7895128 | 0.88 | CYP3A4 (0.49) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL6361059 | 0.84 | CYP3A4 (0.75) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL4429395 | 0.82 | ALDH1A1 (0.39) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL31542614 | 0.80 | CYP3A4 (0.80) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL434686 | 0.80 | CYP3A4 (0.80) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL6272567 | 0.78 | MAOA (0.54) | CYP3A4ALDH1A1MAPTHPGDKDM4E | |
| SCHEMBL30945593 | 0.75 | PDE4D (0.55) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL4426240 | 0.75 | KCNA3 (0.40) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| Bergaptol SCHEMBL31097369 | 0.73 | ALDH1A1 (1.00) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 | |
| SCHEMBL30226185 | 0.73 | CYP3A4 (0.65) | CYP3A4ALDH1A1MAPTHPGDCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220106268-A9 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M. YARBROUGH FOUNDATION | 2022-04-07 | — | — | US | disclosed |
| US-11279674-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2022-03-22 | — | — | US | disclosed |
| US-11279674-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2022-03-22 | — | — | US | disclosed |
| US-20210355081-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | SILVER MICHAEL E (US) | 2021-11-18 | — | — | US | disclosed |
| US-20210355081-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | SILVER MICHAEL E (US) | 2021-11-18 | — | — | US | disclosed |
| US-10647668-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2020-05-12 | — | — | US | disclosed |
| US-10647668-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2020-05-12 | — | — | US | disclosed |
| US-20190284133-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M. YARBROUGH FOUNDATION | 2019-09-19 | — | — | US | disclosed |
| US-20190284133-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M. YARBROUGH FOUNDATION | 2019-09-19 | — | — | US | disclosed |
| US-10308600-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2019-06-04 | — | — | US | disclosed |
| WO-2013003601-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2013-01-03 | — | — | WO | disclosed |
| WO-2013003601-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2013-01-03 | — | — | WO | disclosed |
| US-8318973-B2 | Functionalized sinapic acid and methyl sinapate | BEZWADA BIOMEDICAL, LLC (US) | 2012-11-27 | — | — | US | disclosed |
| US-8318973-B2 | Functionalized sinapic acid and methyl sinapate | BEZWADA BIOMEDICAL, LLC (US) | 2012-11-27 | — | — | US | disclosed |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | WILLIAM M. YARBROUGH FOUNDATION, THE | 2012-07-19 | — | — | US | disclosed |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | WILLIAM M. YARBROUGH FOUNDATION, THE | 2012-07-19 | — | — | US | disclosed |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | WILLIAM M. YARBROUGH FOUNDATION, THE | 2012-07-19 | — | — | US | disclosed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| WO-2007053794-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355081-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | STOM, TST, ABCB4 | CYP3A4 3387/4885ALDH1A1 3440/4885MAPT 1700/4885 |
| US-10308600-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
| US-11279674-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | COMT, AOX1, UGT1A6 | CYP3A4 345/4885ALDH1A1 384/4885MAPT 2351/4885 |
| US-10647668-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
| US-20220106268-A9 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
| US-20190284133-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | CYP3A4 3874/4885ALDH1A1 3753/4885MAPT 2844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.